Dermatology

Brodalumab, guselkumab, ixekizumab, and risankizumab show highest response rates

Prevention is the key to minimizing sun-induced skin damage. This includes patient education regarding appropriate sun protection, as well as informing patients of the potential for certain medications to cause photosensitization before they start therapy.

Provide guidance on vaccinating adults receiving immunosuppressive medications and infants following intrauterine exposure to these agents

Patients may be trained to self-administer by subcutaneous injection every 12 weeks during maintenance therapy

Pharmacists encouraged to provide clear messages about medication, work with physicians.

Provides practical guidance on optimal care of patients with moderate-to-severe atopic dermatitis